Published in Blood Weekly, December 21st, 2006
Study 1: Advanced-stage nonsmall cell lung cancer (NSCLC) could be prognosticated by a newly developed prediction equation.
"A pooled analysis was performed to examine the impact of pretreatment factors on overall survival (OS) and time to progression (TTP) in patients with advanced-stage NSCLC and to construct a prediction equation for OS using pretreatment factors. A pooled data set of 1053 patients from 9 North Central Cancer Treatment Group trials was used," researchers in the United States reported.
"Age, gender, Eastern Cooperative Oncology Group performance...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.